Pharvaris (PHVS) director Monges sells 9,667 shares, updates ownership

Rhea-AI Filing Summary

Pharvaris N.V. director Viviane Monges sold 9,667 shares of Common Stock in an open-market transaction. The sale occurred on May 21, 2026 at a weighted average price of $30.2941 per share, with individual trade prices ranging from $30.08 to $30.49 per share.

The shares sold were previously acquired upon vesting of restricted stock units granted as equity compensation. Following this transaction, Monges directly holds 5,500 Pharvaris shares. A footnote also corrects prior beneficial ownership reported on a Form 3, which had understated holdings by 513 shares due to earlier administrative errors in tax-withholding records.

Insights

Equity compensation and governance analyst

Director executes modest RSU-related sale and corrects prior ownership.

Director Viviane Monges sold 9,667 Pharvaris shares in an open-market transaction at a weighted average price of $30.2941. The filing clarifies that these shares came from vested restricted stock units, tying the sale to equity compensation rather than a new discretionary acquisition.

After the sale, Monges holds 5,500 shares directly, so she retains an ongoing equity stake. The form also corrects an earlier Form 3, noting prior beneficial ownership had been understated by 513 shares due to administrative errors in tax-withholding records. This update mainly improves record accuracy without indicating a change in company fundamentals.

Insider Trade Summary

Net Seller: 9,667 shares ($292,853)

Net Sell 1 txn

Insider Monges Viviane

Role null

Sold 9,667 shs ($293K)

Type	Security	Shares	Price	Value
Sale	Common Stock	9,667	$30.2941	$293K

Holdings After Transaction: Common Stock — 5,500 shares (Direct, null)

Footnotes (1)

1. The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 513 shares due to administrative errors in the number of shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026. This filing reflects the corrected beneficial ownership amount. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.49 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 9,667 shares Weighted average sale price: $30.2941 per share Sale price range: $30.08–$30.49 per share +3 more

6 metrics

Shares sold 9,667 shares Open-market sale on May 21, 2026

Weighted average sale price $30.2941 per share Common Stock sale

Sale price range $30.08–$30.49 per share Multiple transactions on May 21, 2026

Shares held after transaction 5,500 shares Post-sale direct ownership

Net shares sold 9,667 shares Net-sell direction in transaction summary

Ownership understatement correction 513 shares Prior Form 3 beneficial ownership adjustment

Key Terms

restricted stock units, beneficially owned, weighted average sale price, withheld for tax obligations, +1 more

5 terms

restricted stock units financial

"The shares sold were acquired upon vesting of restricted stock units on various dates."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

beneficially owned financial

"The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated..."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

weighted average sale price financial

"The reported price represents a weighted average sale price for shares sold in multiple transactions..."

withheld for tax obligations financial

"...shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026."

Form 3 regulatory

"The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated..."

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monges Viviane

(Last) (First) (Middle)

1 CRANBERRY HILL SUITE 400

(Street)

LEXINGTON MASSACHUSETTS 02421

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pharvaris N.V. [ PHVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/21/2026		S		9,667(1)	D	$30.2941(2)	5,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The total number of shares beneficially owned previously reported in the Form 3 filed on March 18, 2026 was understated by 513 shares due to administrative errors in the number of shares reported as withheld for tax obligations in connection with RSU releases occurring on April 11, 2025 and March 12, 2026. This filing reflects the corrected beneficial ownership amount.

2. The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $30.08 to $30.49 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	/s/ Marnus Nel, Attorney-in-Fact for Viviane Monges	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Pharvaris (PHVS) director Viviane Monges report in this Form 4?

Viviane Monges reported selling 9,667 Pharvaris Common Stock shares in an open-market transaction. The sale occurred at a weighted average price of $30.2941 per share, and she now directly holds 5,500 shares after the transaction.

At what price did Viviane Monges sell Pharvaris (PHVS) shares?

The reported sale used a weighted average price of $30.2941 per share. Individual trades occurred between $30.08 and $30.49 per share, with the director offering to provide full price-by-lot details to interested parties upon request.

How many Pharvaris (PHVS) shares does Viviane Monges own after this transaction?

Following the reported sale, Viviane Monges directly holds 5,500 Pharvaris Common Stock shares. The filing shows this post-transaction balance and clarifies that the sold shares were originally received through restricted stock unit vesting.

Were the Pharvaris (PHVS) shares sold by Viviane Monges from equity compensation?

Yes. The filing states the sold shares were acquired upon vesting of restricted stock units. This means they originated from equity compensation awards, not prior open-market purchases, and were later sold in multiple transactions at market prices.

What correction to prior Pharvaris (PHVS) ownership did the filing disclose?

The filing explains that a prior Form 3 understated Viviane Monges’ beneficial ownership by 513 shares. The error arose from misreporting shares withheld for tax obligations on RSU releases, and the new form now reflects the corrected ownership total.